EP1572:: A novel peptido-mimetic GH secretagogue with potent and selective GH-releasing activity in man

被引:41
作者
Broglio, F
Boutignon, F
Benso, A
Gottero, C
Prodam, F
Arvat, E
Ghè, C
Catapano, F
Torsello, A
Locatelli, V
Muccioli, G
Boeglin, D
Guerlavais, V
Frehrentz, JA
Martinez, J
Ghigo, E
Deghenghi, R
机构
[1] Univ Turin, Dept Internal Med, Div Endocrinol, I-10126 Turin, Italy
[2] Univ Turin, Dept Anat Pharmacol & Forens Med, I-10126 Turin, Italy
[3] Univ Milano Bicocca, Dept Expt & Environm Med & Biotechnol, Milan, Italy
[4] Europeptides, Argenteuil, France
[5] Univ Montpellier, Lab Aminoacides Peptides & Prot, Montpellier, France
关键词
synthetic GH secretagogues; GH; ghrelin receptors; oral administration; humans;
D O I
10.1007/BF03345096
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
EP1572 (JMV1843 [Aib-DTrp-DgTrp-CHO]) is a new peptido-mimetic GH secretagrogue (GHS) showing binding potency to the GHS-receptor in animal and human tissues similar to that of ghrelin and peptidyl GHS. EP1572 induces marked GH increase after sc administration in neonatal rats. Preliminary data in 2 normal young men show that: 1) acute iv EP1572 administration (1.0 mug/kg) induces strong and selective increase of GH levels; 2) single oral EP1572 administration strongly and reproducibly increases GH levels even after a dose as low as 0.06 mg/kg. Thus, EP 1572 is a new peptido-mimetic GHS with potent and selective GH-releasing activity.
引用
收藏
页码:RC26 / RC28
页数:3
相关论文
共 9 条
[1]   Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: Comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone [J].
Arvat, E ;
Maccario, M ;
Di Vito, L ;
Broglio, F ;
Benso, A ;
Gottero, C ;
Papotti, M ;
Muccioli, G ;
Dieguez, C ;
Casanueva, FF ;
Deghenghi, R ;
Camanni, F ;
Ghigo, E .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (03) :1169-1174
[2]   Purification and distribution of ghrelin: The natural endogenous ligand for the growth hormone secretagogue receptor [J].
Kojima, M ;
Hosoda, H ;
Kangawa, K .
HORMONE RESEARCH, 2001, 56 :93-97
[3]   Ghrelin: discovery of the natural endogenous ligand for the growth hormone secretagogue receptor [J].
Kojima, M ;
Hosoda, H ;
Matsuo, H ;
Kangawa, K .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2001, 12 (03) :118-122
[4]  
MARTINEZ J, 2001, Patent No. 0196300
[5]   Specific receptors for synthetic GH secretagogues in the human brain and pituitary gland [J].
Muccioli, G ;
Ghé, C ;
Ghigo, MC ;
Papotti, M ;
Arvat, E ;
Boghen, MF ;
Nilsson, MHL ;
Deghenghi, R ;
Ong, H ;
Ghigo, E .
JOURNAL OF ENDOCRINOLOGY, 1998, 157 (01) :99-106
[6]   Neuroendocrine and peripheral activities of ghrelin:: implications in metabolism and obesity [J].
Muccioli, G ;
Tschöp, M ;
Papotti, M ;
Deghenghi, R ;
Heiman, M ;
Ghigo, E .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2002, 440 (2-3) :235-254
[7]   Binding of 125I-labeled ghrelin to membranes from human hypothalamus and pituitary gland [J].
Muccioli, G ;
Papotti, M ;
Locatelli, V ;
Ghigo, E ;
Deghenghi, R .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2001, 24 (03) :RC7-RC9
[8]   Peptidomimetic regulation of growth hormone secretion [J].
Smith, RG ;
VanderPloeg, LHT ;
Howard, AD ;
Feighner, SD ;
Cheng, K ;
Hickey, GJ ;
Wyvratt, MJ ;
Fisher, MH ;
Nargund, RP ;
Patchett, AA .
ENDOCRINE REVIEWS, 1997, 18 (05) :621-645
[9]   Novel hexarelin analogs stimulate feeding in the rat through a mechanism not involving growth hormone release [J].
Torsello, A ;
Luoni, M ;
Schweiger, F ;
Grilli, R ;
Guidi, M ;
Bresciani, E ;
Deghenghi, R ;
Muller, EE ;
Locatelli, V .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 360 (2-3) :123-129